By Dr. Kayla Wright, DPM
A 2024 meta-analysis directly comparing the two favored shockwave at three months for pain and foot function. That does not mean shockwave is always better, nor does it mean cortisone is inherently unsafe. The decision depends on where you are in the treatment course and what tradeoffs matter most.
Shockwave vs. cortisone at a glance
| Consideration | Shockwave therapy (ESWT) | Corticosteroid injection |
|---|---|---|
| Invasive? | No incision or needle into the fascia | Injection through the skin |
| Typical goal | Improve pain/function in persistent plantar fasciitis | Reduce pain, often with an emphasis on shorter-term relief |
| Speed | Improvement may build over weeks | Can provide relatively faster relief in responders |
| Evidence | Better than sham in many studies; results vary vs active treatments | Evidence supports short-term benefit, with less convincing sustained superiority |
| Main limitations | Cost, discomfort, multiple protocols/devices, variable response | Injection discomfort, temporary response, and concern for tissue complications, especially with repeated exposure |
| Role in rehab | Should complement diagnosis and load/strength program | Should not substitute for addressing load and function |
What does cortisone actually do?
A corticosteroid injection delivers anti-inflammatory medication to the symptomatic region. It can reduce pain in the short term, which may be valuable when symptoms are significantly limiting walking or function.
But plantar fasciitis is not simply an acute inflammatory condition. Chronic cases show degenerative and load-related tissue changes, which helps explain why suppressing pain does not necessarily address the mechanical factors that produced the problem.
Systematic reviews have generally found that corticosteroid injections can improve pain over the short term, while longer-term advantages are less consistent.
What does shockwave do?
ESWT delivers mechanical acoustic pulses to the plantar heel. Its exact clinical mechanism is still being studied, but proposed effects involve mechanotransduction, tissue signaling, vascular responses, and pain modulation.
The practical distinction is that ESWT is not primarily a rapid anti-inflammatory injection. It is usually positioned as a noninvasive treatment for persistent cases, with improvement measured over weeks to months.
Metro's evidence-focused guide explains what current research shows about shockwave for plantar fasciitis.
Which one works better?
The fairest answer is it depends on the time point and outcome.
A 2024 systematic review and meta-analysis included 16 randomized studies with 1,121 patients directly comparing ESWT with corticosteroid injections. At three months, ESWT showed better pooled outcomes for pain reduction, plantar-fascia thickness, and foot function.
An earlier 2019 meta-analysis also found both treatments effective, with some pain outcomes favoring shockwave.
However, broader reviews of plantar-heel-pain treatments have found substantial heterogeneity and uncertainty when many active interventions are compared. That is why a single pooled result should inform the decision rather than dictate it.
The useful takeaway:
Cortisone may be attractive when short-term symptom relief is the priority; shockwave may be attractive when a patient with persistent symptoms wants a noninvasive escalation option and can accept a more gradual response.
What are the risks of cortisone in the heel?
Corticosteroid injections are widely used, and serious complications are uncommon in randomized trials. Still, the foot-and-ankle literature recognizes potential complications including:
- plantar fascia rupture
- heel fat-pad atrophy
- infection
- skin or pigmentation changes
- post-injection pain
The absolute risk is difficult to quantify precisely because adverse events are inconsistently reported and many trials have short follow-up. Case series have historically raised particular concern around repeated injections.
That is why cortisone should not be portrayed as either harmless or dangerous by default. Dose, location, technique, frequency, patient factors, and prior injections matter.
What are the downsides of shockwave?
Shockwave avoids an injection into the fascia, but it has its own tradeoffs:
- treatment can be uncomfortable
- several visits may be required depending on the protocol
- not every patient improves
- different technologies and dosing protocols make results harder to generalize
- insurance coverage can vary
- the response may take time
A noninvasive treatment is not automatically a better treatment; it still needs the right diagnosis and indication.
Neither option should come before the basics
Before comparing procedures, make sure first-line care has been addressed. The 2023 plantar-fasciitis clinical practice guideline supports:
- plantar fascia and calf stretching
- therapeutic resistance exercise for the foot and ankle
- taping in selected patients
- night splints for persistent first-step pain
- orthoses when used as part of combined treatment rather than alone
Most plantar fasciitis improves without surgery, and many patients will never need either shockwave or an injection.
A practical decision framework
Shockwave may be worth discussing when:
- symptoms have persisted for months
- the diagnosis is well established
- a structured conservative program has not produced adequate improvement
- you prefer a noninvasive treatment
- you are comfortable with improvement that may be gradual
Cortisone may be worth discussing when:
- symptoms are substantially limiting function
- short-term pain reduction has meaningful value
- the diagnosis is clear
- the clinician believes the risk-benefit profile is reasonable
- there is a plan for what happens after pain improves
Reconsider both when:
- the diagnosis is uncertain
- focal bone pain raises concern for stress injury
- neurologic symptoms suggest nerve involvement
- pain is predominantly posterior rather than plantar
- treatment has been escalating without a meaningful rehabilitation plan
What if you have already had a cortisone injection?
A prior injection does not automatically rule out future treatment, but it becomes part of the risk calculation. The number of prior injections, response duration, injection location, tissue status, and alternative options all matter.
If an injection helped for only a few weeks and the same loading pattern remains, simply repeating the exact approach may offer diminishing value.
Frequently asked questions
Is shockwave safer than cortisone?
They have different risk profiles. ESWT avoids an injection and the specific injection-related concerns around plantar fascia rupture and fat-pad injury, but it can cause discomfort and has device/protocol-specific precautions. “Safer” should be judged for the individual patient.
Does cortisone cure plantar fasciitis?
No treatment should be described as a guaranteed cure. Cortisone can reduce symptoms, particularly in the short term, but plantar-fasciitis management also involves load, mobility, strength, footwear, and other factors.
Can shockwave and cortisone be used at different times?
Potentially. Treatment sequencing is individualized and should account for prior response, tissue risk, diagnosis, and goals. There is no universal sequence that every patient should follow.
Is shockwave worth paying out of pocket for?
That depends on the diagnosis, symptom duration, quality of prior conservative care, proposed protocol, cost, and how much the condition limits your life. Ask what exact technology is being used, what outcomes are realistic, and what alternatives remain.
Which option gets athletes back faster?
There is no reliable universal answer. Temporary pain reduction is not the same as restored tissue capacity. Return to running or sport should be based on symptoms, function, strength, and progressive load tolerance rather than the treatment name alone.
Comparing plantar-fasciitis treatment options in Tempe
If plantar fasciitis has remained limiting despite a structured treatment program, the next decision should begin with confirming the diagnosis and reviewing what has already been tried—not choosing a procedure from a menu.
Metro Foot & Ankle evaluates persistent heel pain and treatment options for patients in Tempe and throughout the East Valley. To discuss the tradeoffs for your specific case, request an evaluation.
This article is for general educational purposes and does not replace individualized medical advice, diagnosis, or treatment.
Sources
- Cortés-Pérez I, Moreno-Montilla L, Ibáñez-Vera AJ, et al. Efficacy of extracorporeal shockwave therapy, compared to corticosteroid injections, on pain, plantar fascia thickness and foot function in patients with plantar fasciitis: A systematic review and meta-analysis. Clinical Rehabilitation. 2024;38(8):1023-1043. https://pubmed.ncbi.nlm.nih.gov/38738305/ (opens in a new tab)
- Xiong Y, Wu Q, Mi B, et al. Comparison of efficacy of shock-wave therapy versus corticosteroids in plantar fasciitis: a meta-analysis of randomized controlled trials. Archives of Orthopaedic and Trauma Surgery. 2019;139(4):529-536. https://pubmed.ncbi.nlm.nih.gov/30426211/ (opens in a new tab)
- Whittaker GA, Munteanu SE, Menz HB, et al. Corticosteroid injection for plantar heel pain: a systematic review and meta-analysis. BMC Musculoskeletal Disorders. 2019;20:378. https://pmc.ncbi.nlm.nih.gov/articles/PMC6698340/ (opens in a new tab)
- David JA, Sankarapandian V, Christopher PRH, Chatterjee A, Macaden AS. Injected corticosteroids for treating plantar heel pain in adults. Cochrane Database of Systematic Reviews. 2017. https://pmc.ncbi.nlm.nih.gov/articles/PMC6481652/ (opens in a new tab)
- Koc TA Jr, Bise CG, Neville C, et al. Heel Pain – Plantar Fasciitis: Revision 2023. J Orthop Sports Phys Ther. 2023;53(12):CPG1–CPG39. https://www.orthopt.org/content/s/heel-pain-plantar-fasciitis-revision-2023 (opens in a new tab)
- American Academy of Orthopaedic Surgeons. Plantar Fasciitis and Bone Spurs. https://orthoinfo.aaos.org/en/diseases--conditions/plantar-fasciitis-and-bone-spurs (opens in a new tab)